Send us Feedback

Avant Immunotherapeutics (AVAN)
Analysis
SUMMARY
BULLS
BEARS
TOPICS
Data
DATA CENTRAL
STOCK CHART
Financials
SEC FILINGS
BALANCE
INCOME
CASH FLOW

AVAN » Topics » AGGREGATE CONTRACTUAL OBLIGATIONS

This excerpt taken from the AVAN 10-K filed Mar 16, 2005.

AGGREGATE CONTRACTUAL OBLIGATIONS

        The following table summarizes AVANT's contractual obligations at December 31, 2004 and the effect such obligations and commercial commitments are expected to have on its liquidity and cash flow

49


in future years. These obligations, commitments and supporting arrangements represent payments based on current operating forecasts, which are subject to change:

 
   Total
   Less than
One Year
   1-3 Years
   3-5 Years
   4-5 Years
Contractual obligations:                              
Operating lease obligations   $ 6,822,100   $ 2,446,800   $ 3,837,100   $ 538,200   $ —
Long-Term liabilities*     1,922,300     297,900     1,027,000     471,500     125,900
Licensing obligations     695,000     185,000     255,000     170,000     85,000
Construction contracts     117,100     117,100     —     —     —
   
 
 
 
 
  Total contractual obligations   $ 9,556,500   $ 3,046,800   $ 5,119,100   $ 1,179,700   $ 210,900
   
 
 
 
 

Commercial commitments:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Clinical development   $ 2,164,700   $ 2,164,700   $ —   $ —   $ —
Manufacturing development     4,142,400     2,342,400     1,800,000     —     —
   
 
 
 
 
  Total commercial commitments   $ 6,307,100   $ 4,507,100   $ 1,800,000   $ —   $ —
   
 
 
 
 
*
includes interest obligations
Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki